Please login to the form below

Not currently logged in
Email:
Password:

Array Biopharma

This page shows the latest Array Biopharma news and features for those working in and with pharma, biotech and healthcare.

Merck buys ArQule for $2.7bn in another cancer bolt-on deal

Merck buys ArQule for $2.7bn in another cancer bolt-on deal

Others have included GlaxoSmithKline’s $5.1bn takeover of  Tesaro, Pfizer’s $11.4bn acquisition of  Array Biopharma, Eli Lilly’s  Loxo Oncology deal valued at $8bn and Merck’s

Latest news

More from news
Approximately 1 fully matching, plus 11 partially matching documents found.

Latest Intelligence

  • 20 for 2020 – Five pharma leaders to watch in 2020 20 for 2020 – Five pharma leaders to watch in 2020

    The latter includes its $11.4bn deal to buy Array Biopharma – the biggest for the group since its $14.3bn takeover of cancer specialist Medivation – that added two marketed drugs (Mektovi ... It’s all part of a plan that Maraganore thinks could

  • Deal Watch November 2015 Deal Watch November 2015

    Acquisition - assets. Marketed global dermatology portfolio. 724. Array BioPharma. Pierre Fabre.

  • Deal Watch table for December 2014 Deal Watch table for December 2014

    Exclusive negotiations to create 5-year strategic alliance. 310. Array BioPharma / Oncothyreon. ... ex Japan. original deal headline value. ex US, JP. † If Oncothyreon is acquired with 3 years of effective date, Array eligible for up to $280m milestones

  • Deal Watch table for July 2013 Deal Watch table for July 2013

    485. Array BioPharma / Loxo Oncology. Multi-year licence and collaboration. Drug candidate (preclinical) discovery of small molecule drugs for oncology targets. ... 434. Array BioPharma / Celgene. Collaboration and option. Programme targeting novel

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • Array appoints Victor Sandor chief medical officer Array appoints Victor Sandor chief medical officer

    He joins from Incyte and will replace Michael Needle. Array Biopharma has named Victor Sandor as its new chief medical officer, handing him responsibility for leading clinical, medical and regulatory strategy ... Ron Squarer, CEO at Array Biopharma, said:

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, scientific and medical communication services to the pharmaceutical industry across the globe, with...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics